Publication | Closed Access

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

Phase Ii TrialMedicinePathologyBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung CancerCancer ResearchIsis 5132